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Available online 6 April 2016Extraintestinal pathogenic Escherichia coli sequence type 131 (ST131), typically ﬂuoroquinolone-resistant (FQ-R)
and/or extended-spectrum β-lactamase (ESBL)–producing, has emerged globally. Among clinical isolates, ST131,
primarily its H30-R and H30-Rx subclones, accounts for most antimicrobial-resistant E. coli and is the dominant
E. coli strain worldwide. We assessed its prevalence and characteristics among raw chicken meat samples on sale
in Palermo, Italy. A collection of 237 ﬂuoroquinolone resistant and ESBL/AmpC producing E. coli isolates, which
had been isolated fromprocessed retail chickenmeat in the periodMay2013–April 2015,was analyzed. Established
polymerase chain reaction methods were used to deﬁne ST131 and its H30 subclones, ESBL, AmpC, and plasmid-
mediated quinolone resistance (PMQR) determinants. Ampliﬁed Fragment Length Polymorphism (AFLP) was per-
formed to assess the relatedness among ST131 isolates. Out of the 237 E. coli isolates, 12 isolates belonged to the
phylogenetic group B2. Based on the molecular deﬁnition of ExPEC, all isolates were attributed with the status of
ExPEC. SNP-PCR results conﬁrmed that nine isolateswere ST131. SNP-PCR forH30-R andH30-Rx subclones showed
that six and three ExPEC ST131 were positive for H30-R and H30-Rx, respectively. The results of AFLP showed that,
except for four isolates grouped into two clusters which proved to be indistinguishable, the isolates under study
were genetically heterogeneous. To the best of our knowledge, this is theﬁrst report ofH30-R andH30-Rx subclones
in animal food samples. Our ﬁndings appear to support the role of food chain in their transmission to humans.
© 2016 Elsevier B.V. All rights reserved.Keywords:
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AFLP1. Introduction
Extraintestinal pathogenic Escherichia coli (ExPEC) sequence type
(ST131), belonging to the phylogenetic group B2, has been reported to
cause a wide range of extraintestinal infections, including 70–95% of
cases of urinary tract infections (UTI), worldwide (Kim, 2012). In
2008, the previously undeﬁned E. coli clonal group ST131was identiﬁed
in three continents. Today, ST131 is the predominant E. coli lineage
among ExPEC isolates worldwide (Nicolas-Chanoine et al., 2014).
The ST131isolates commonly harbor a large number of virulence-
associated genes (Banerjee and Johnson, 2014; Blanco et al., 2013;
Singer, 2015). Moreover, ExPEC ST131 isolates are commonly reported
to be ﬂuoroquinolones resistant (FQ-R) and to produce extended-
spectrum β-lactamases (ESBLs), such as CTX-M-15 (Banerjee and
Johnson, 2014). Recent molecular epidemiologic studies have elucidat-
ed the clonal structure of ST131, which includes multiple ST131
subclones with distinctive resistance proﬁles, including H30, H30-R,
and H30-Rx (Banerjee et al., 2013; Johnson et al., 2015; Price et al.,
2013). Potential reservoirs of ST131 include food animals and the foodHealth Promotion and Mother-
alermo, Italy.
ina).chain, but to date isolates of ST131 have been only sporadically detected
among commercial animals and food items (Vincent et al., 2010).
The aim of this study was to investigate the prevalence of ExPEC
ST131 and its main subclones H30-R and H30-Rx in retail chicken
meat on sale in the area of Palermo, Italy.
2. Materials and methods
A collection of 237 ﬂuoroquinolone resistant and ESBL/AmpC pro-
ducing E. coli isolates, which had been isolated from retail chicken
meat sampled in the period May 2013–April 2015 in Palermo, Italy,
was included in this study. One hundred sixty-six out of the 237 isolates
had been previously described (Ghodousi et al., 2015).
2.1. PCR analysis of phylogenetic groups and virulence genes
E. coli isolateswere assigned to one of the four designatedphylogenet-
ic group (A, B1, B2, or D) based on the pattern of chuA, yjaA, and TSPE4.C2
genes presence, as described by Clermont et al. (2000). ExPEC classiﬁca-
tion of isolateswas based on the presence of two ormore of the following
virulence genes: pap (P ﬁmbriae), sfa or foc (S/F1C ﬁmbriae), afa or dra
(binding, adhesions), iutA (aerobactin receptor), and kpsM II (group II
capsule synthesis) as described (Johnson et al., 2009). E. coli RS218
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focG), E. coli 2H16 (papC, iutA, afa, hlyD), and E. coli J96 (papA, focG)
were used as positive control strains. E. coliMG1655 was used as a nega-
tive control in the reactions.
2.2. Antibiotic resistance genotyping
ESBL/AmpC production was screened in all B2 isolates by using the
double-disk synergy test and cephalosporin resistance according with
the EUCAST guidelines. ESBL genotype was determined by multiplex
PCR using published TEM, SHV, CTX-M-1, CTX-M-2 and CTX-M-9
group-speciﬁc primers. A plasmid-mediated AmpC β-lactamase genes
targeting PCR, including six groups of the ACC, FOX, MOX, DHA, CIT,
and EBC groups, respectively, was performed (Dallenne et al., 2010).
All B2 isolates were investigated for the presence of qnrA, qnrB, qnrS
and aac(6′)-Ib genes according with Cattoir et al. (Cattoir et al., 2007).
2.3. PCR-based detection of blaCTX-M-15
The CTX-M-15-encoding gene blaCTX-M-15 was detected by PCR using
single nucleotide polymorphism (SNP)-speciﬁc forward primer 5′-
ATAAAACCGGCAGCGGTGG-3′ and universal reverse primer 5′-GAAT
TTTGACGATCGGGG-3′ (Johnson et al., 2012). PCR protocol included
10min of pre-denaturation at 95 °C, subsequently followed by 33 cycles
of 30 s at 94 °C, and 30 s at 67 °C and ﬁnally one cycle of 7 min at 72 °C
post elongation step. The blaCTX-M-15-speciﬁc 483 bp PCR product was
detected by agarose gel electrophoresis. E. coli strains MVAST131 and
JJ1886 were used as negative and positive control strains, respectively
(Price et al., 2013).
2.4. Identiﬁcation of ST131 clone
All group B2 isolates were screened by PCR for the ST131-associated
SNPs in mdh and gyrB (Johnson et al., 2010; Johnson et al., 2014). E. coli
strains MVAST131, JJ1886 and BUTI 1-2-1 (H17) were used as positive
control strains and E. coli MG1655 was used as a negative control
(Moulin-Schouleur et al., 2007).
2.5. H30 complex subclone detection and detection of H30-R/Rx-speciﬁc
SNPs
According to the PCR-based screening, ST131 isolates were classiﬁed
as the H30 complex subclone if they contained H30-speciﬁc polymor-
phisms in ﬁmH (Price et al., 2013). E. coli strains MVAST131 and
JJ1886 were used as positive control strains.
Two SNPs that differentiate the CTX-M-15-associated subclone
(H30-Rx) within the H30-R subclone from the rest of the H30 complex
subclone were interrogated using Sanger sequencing. SNP-200 was de-
tected as a C-to-T transition at position 299 of the 460-bp PCR product
generated using forward primer 5′-GACACCATGCGTTTTGCTTC-3′ and
reverse primer 5′-TCGTACCGG CAACAATTGAC-3′. SNP-264 was detect-
ed as a G-to-A transition at position 287 of the 462-bp PCR product gen-
erated using forward primer 5′-GTGGCGATTTCACGCTGTT-3′ and
reverse primer 5′ TATCCAGCACGTTCCAGGTG 3′. Isolates that tested
positive for both SNPs were regarded as members of the H30-Rx
subclone. E. coli strain JJ1886 was used as positive control strain.
2.6. Molecular typing
Ampliﬁed Fragment Length Polymorphism (AFLP) was used for mo-
lecular typing of ST131 isolates (Kumar et al., 2013). Primers (Euroﬁns
Genomics, Ebersberg, Germany) were dissolved in sterile water. FAM-
labeled EcoR1 primers were dissolved in 10 mM Tris–HCl pH 8.0. EcoRI
adapters were constructed from the following primers: EcoRI-1 5′-
CTCGTAGACTGCGTACC-3′ and EcoRI-2 5′-AATTGGTACGCAGTCTAC-3′.
MseI adapters were constructed from the following primers: MseI-15′-GACGATGAGTCCTGA G-3′ andMseI-2 5′-TACTCAGGACTCAT-3′. For
PCR ampliﬁcation EcoRI primer 5′-GACTGCGTACCAATT C-3′ and MseI
primer 5′-GATGAGTCC TGAGTAACC-3′ were used. The EcoR1 primer
contains no selective nucleotide and theMse1 primer contains 2 selec-
tive (\\CC) nucleotides.
DNA (250 ng) was digested for 2.5 h at 37 °C with 10 U EcoRI and
10 UMseI ((New England BioLabs, Ipswich, UK) and 50 ng DNA equiva-
lent was ligated to 0.25 μM EcoRI and 2.5 μMMseI adapters with 1 U T4
DNA ligase ((New England BioLabs, Ipswich, UK) for 3 h at 37 °C.
The EcoR1 primer (5 μM), Mse1 primer (10 μM), 1× PCR buffer, 1
0.5 mM MgCl2, 0.2 mM dNTPs, and 1 U DynazymeII ((Finnzymes Diag-
nostics, Thermo Scientiﬁc, Wilmington, DE, US) were used to amplify
2.5 ng DNA restriction fragment equivalent with the following cycling
protocol: 2 min 94 °C, 13 × (30 s 94 °C; 30 s 65 °C, decreasing 0.7 °C
every cycle; 1 min 72 °C) and 10 min 72 °C, 27 × (30 s 94 °C; 30 s
56 °C; 1 min 72 °C) on an Icycler thermocycler (Bio-Rad Laboratories,
Hercules, CA, US).
The restriction/ligation product was diluted 20 times in sterile TE
buffer and subjected to the PCR with the EcoRI-G and MseI-A AFLP
primers. PCR fragments were heat-denatured in the presence of Hi-
Di™ formamide (Applied Biosystems) and Genescan™ 1200-LIZ size
standard (Applied Biosystems) and separated by capillary electrophore-
sis using a 3130 GeneticAnalyzer (Applied Biosystems). Data were ini-
tially analyzed with GeneMapper V4.0 software and further processed
in BioNumerics (version 7.1; Applied Maths, Sint-Martens-Latem,
Belgium). PCR fragments (80–700 bp) were analyzed with peak detec-
tion settings of 0.2% of OD range and 2% of curve range. Pearson similar-
ity matrix combined with UPGMA clustering hierarchy and PCA was
applied to analyze data in BioNumerics v. 6.1 software (Applied
Maths, Sint-Martens-Latem, Belgium).
3. Results
Out of the 237 E. coli isolates, 12 isolates (5.1%) proved to belong to
the phylogenetic group B2. Double-disk synergy test results showed
that all B2 isolates were putative ESBL producers. Moreover, they
proved to be resistant to ciproﬂoxacin by disk diffusion test according
with the European Committee on Antimicrobial Susceptibility Testing
(EUCAST) guidelines (http://www.eucast.org/clinical_breakpoints/).
The complete results of the PCR tests for the antibiotic resistance de-
terminants are shown in Table 1. Based upon the molecular deﬁnition,
the 12 B2 isolates were all attributed with the status of ExPEC. The
most prevalent virulence factors were kpsMT II and iutA (Table 1).
SNP-PCR results conﬁrmed that nine out of the 12 B2 isolates were
ST131. These isolates were positive for both ESBL and PMQR determi-
nants. SNP-PCR for H30-R and H30-Rx subclones showed that six and
three ExPEC ST131 were positive for H30-R and H30-Rx, respectively.
The results of AFLP showed that only two pairs of isolates had indistin-
guishable AFLP proﬁles (N95% similarity), while the remaining isolates
under study were genetically heterogeneous (Fig. 1).
4. Discussion
The prevalence of FQ resistant and/or ESBL producing E. coli ST131 is
increasing rapidly worldwide (Manges and Johnson, 2012; Mora et al.,
2010). The ExPEC isolates from retail poultrymeat have been putatively
associated with human infections (Kluytmans et al., 2013; Manges and
Johnson, 2012) However, only a few studies have investigated the
presence of E. coli ST131 in food animals. In particular, until now there
is no report about detection of E. coli ST131 H30-R/H30-Rx from retail
meat.
The high prevalence of FQ resistant and/or ESBL-producing ExPEC
ST131 in chicken meat in our experience is concerning. Though a com-
parison can be misleading because of substantial differences in sam-
pling of food items and laboratory procedures for E. coli isolation,
previously reported ﬁgures are indicative of lower prevalences.
Table 1
Characteristics of 12 isolates of Escherichia coli belonging to the B2 phylogroup from retail chicken meat, Palermo, Italy, 2015.
Virulence genes Resistance determinants
Nr. ExPEC status ST131 ST131 subclone kpsMll papA sfaS focG afa iut papC CTX-M Amp-C PQMR
43_3 + + H30-R + + − − − + − − − qnrA
68 + + H30-R + − − − − + − − CIT-like qnrA
75_2 + + H30-R + − − + − − − Group 1 non
CTX-M-15
− qnrA
76 + + H30-R + − − + − + − Group 9 − qnrA
94_2 + + H30-R + + − − − + + − − qnrA
140 + + H30-R + − − − − + − Group 2 qnrA
37_2 + + H30-Rx + − − − − + − 15 − qnrA
40_1 + + H30-Rx + − − − − + − 15 − qnrA
46_1 + + H30-Rx + − − − − + − − − qnrA
117 + − / + − − − − + − − − qnrA
137 + − / + − − − − + − − − qnrA
142 + − / + − − − − + − − − qnrA
12 A. Ghodousi et al. / International Journal of Food Microbiology 228 (2016) 10–13Vincent et al. (2010) reported a single non-ESBL-producing ST131 iso-
late from 417 retail chicken samples analyzed. None of the 141 ESBL/
AmpC-producing E. coli isolates from raw chicken imported into the
United Kingdom from South America was identiﬁed as ST131 (Dhanji
et al., 2010). Similarly, Egea et al. (Egea et al., 2012) did not detect at
all the ST131 clone among ESBL-producing E. coli isolates from 33 raw
retail meat samples. Conversely, E. coli ST131 was isolated from seven
out of 100 retail chickenmeat samples analyzed in Spain: three isolates
were resistant to FQ and CTX-M-9 positive; one tested positive for CTX-
M-9 and one was resistant to FQ (Mora et al., 2010).
In our study out of nine isolates of ExPEC ST131, six and three, re-
spectively, were attributed to the H30-R and H30-Rx subclones. To the
best of our knowledge, this is the ﬁrst report of the ExPEC ST131
subclones H30-R and H30-Rx in retail chicken meat. Of the three H30-
Rx positive isolates two carried blaCTX-M-15 and one did not. This ﬁnding
is consistent with literature data showing that some H30-Rx E. coli iso-
lates do not carry blaCTX-M-15 (Price et al., 2013). A precise evolutionary
history of CTX-M-15 acquisition in H30-Rx is still unavailable yet, but it
has been hypothesized that this subclonemight be under stronger anti-
biotic selective pressure due to its virulence, causing a more frequent
use of antimicrobial therapy compared to other E. coli lineages (Price
et al., 2013). The ﬁndings of our study may be tentatively attributed to
several factors, such as the initial colonization status of broilers before
processing, the degree of fecal contamination of carcasses through
slaughtering, and/or poor hygiene during distribution and marketing
(Altekruse et al., 2002). However, our results require further
conﬁrmation in a larger study.
AFLP showed that, except for two clusters containing two pairs of iso-
lates which proved to be indistinguishable, the isolates under studywereFig. 1. Ampliﬁcation fragment length polymorphism (AFLP) analysis of nine Escherichia coligenetically heterogeneous. The apparent inconsistencies between geno-
mic ﬁngerprinting and antibacterial drug resistance genetic proﬁles
could be attributable to the high genomeplasticity of E. coli and the acqui-
sition of virulence genes, resistance determinants and other functions via
mobile genetic structures such as plasmids, pathogenicity islands, and
othermobile elements (Lanza et al., 2014). Simultaneously, genomic het-
erogeneity supports the possible involvement of poultry meat in the car-
riage through the food chain of many different strains. Contamination of
meat products may, indeed, occur with E. coli from human source during
slaughter, processing and distribution, as opposed to the inferred con-
tamination with avian source isolates. However, the heterogeneity of
our isolates rules reasonably out an artifactual inﬂationof the ST131prev-
alence due to handling by food workers and possible cross-transmission
during the chicken meat processing and marketing steps.
Due to theworldwide increasing demand for poultrymeat products,
their safety is a critical public health issue. DetectingH30-R andH30-Rx
subclones in retail chicken meat can strengthen the hypothesis of the
role of food chain in the acquisition of these pathogenic organisms by
humans.
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